Select Medical
SEM was delisted on the 30th of June, 2026.
254 hedge funds and large institutions have $3.53B invested in Select Medical in 2021 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 76 increasing their positions, 82 reducing their positions, and 17 closing their positions.
370% more call options, than puts
Call options by funds: $19M | Put options by funds: $4.04M
282% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 17
24% more capital invested
Capital invested by funds: $2.84B → $3.53B (+$691M)
22% more funds holding
Funds holding: 208 → 254 (+46)
0.59% more ownership
Funds ownership: 76.27% → 76.86% (+0.59%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
7% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 82
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$16.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.85M |
| 3 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$9.27M |
| 4 |
Renaissance Technologies
New York
|
+$9.06M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$35.4M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
-$18M |
| 3 |
DM
Deerfield Management
New York
|
-$15.6M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$13.4M |
| 5 |
Goldman Sachs
New York
|
-$12.7M |
SEM Hedge Fund Activity: Q1 2021 in Review
254 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q1 2021, worth a combined $3.53B — up 24% from $2.84B a quarter earlier.
Buyers outnumbered sellers: 65 funds opened new SEM positions and 17 closed out — a net gain of 48 holders — while 76 added to existing stakes and 82 trimmed.
The largest buyer was BlackRock, adding an estimated $16.2M. The largest seller was T. Rowe Price Associates, cutting an estimated $35.4M.
- 254 institutional investors held Select Medical (SEM) as of Q1 2021, up from 208 in Q4 2020.
- Funds reported $3.53B of Select Medical stock for Q1 2021, up 24% quarter-over-quarter.
- 65 funds opened new Select Medical positions in Q1 2021 and 17 closed out, a net change of +48 holders.
- The largest Select Medical buyer in Q1 2021 was BlackRock, an estimated $16.2M added.
- The largest Select Medical seller in Q1 2021 was T. Rowe Price Associates, an estimated $35.4M sold.
Based on aggregated 13F filings for Q1 2021.